Kate F. Whitecross

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

Ralph K. Lindemann, Andrea Newbold, Kate F. Whitecross et al. · Proceedings of the National Academy of Sciences · 2007 · 198 citations · Full text

Medicine, Oncology, Pharmacology +17

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11

Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors

Kate F. Whitecross, Amber E. Alsop, Leonie A. Cluse et al. · Blood · 2008 · 81 citations · Full text

Medicine, Oncology, Pharmacology +16

Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin

Andrea Newbold, Ralph K. Lindemann, Leonie A. Cluse et al. · Molecular Cancer Therapeutics · 2008 · 67 citations

Medicine, Oncology, Pharmacology +17

Src Homology 3-Domain Growth Factor Receptor-Bound 2-Like (Endophilin) Interacting Protein 1, a Novel Neuronal Protein that Regulates Energy Balance

James L. Trevaskis, Ken Walder, Victoria C. Foletta et al. · Endocrinology · 2005 · 50 citations · Full text

Life Sciences, Molecular Biology, Physiology +17